1450 related articles for article (PubMed ID: 24910360)
1. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response.
Zhang HL; Azimullah S; Zheng XY; Wang XK; Amir N; Mensah-Brown EP; Al Shamsi M; Shahin A; Press R; Zhu J; Adem A
J Neuroimmunol; 2012 May; 246(1-2):18-26. PubMed ID: 22445739
[TBL] [Abstract][Full Text] [Related]
3. Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis.
Zhang HL; Zheng XY; Zhu J
Cytokine Growth Factor Rev; 2013 Oct; 24(5):443-53. PubMed ID: 23791985
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells.
Li XL; Dou YC; Liu Y; Shi CW; Cao LL; Zhang XQ; Zhu J; Duan RS
Cell Immunol; 2011; 271(2):455-61. PubMed ID: 21889126
[TBL] [Abstract][Full Text] [Related]
5. The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis.
Bao L; Lindgren JU; van der Meide P; Zhu Sw; Ljunggren HG; Zhu J
Brain Pathol; 2002 Oct; 12(4):420-9. PubMed ID: 12408228
[TBL] [Abstract][Full Text] [Related]
6. Are Th17 cells and their cytokines a therapeutic target in Guillain-Barré syndrome?
Wu X; Wang J; Liu K; Zhu J; Zhang HL
Expert Opin Ther Targets; 2016; 20(2):209-22. PubMed ID: 26357850
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic effects of ginkgolides in Guillain-Barré syndrome and experimental autoimmune neuritis.
Li C; Liu S; Aerqin Q; Shen D; Wu X; Liu K
J Clin Neurosci; 2021 May; 87():44-49. PubMed ID: 33863532
[TBL] [Abstract][Full Text] [Related]
8. M1 Macrophage Derived Exosomes Aggravate Experimental Autoimmune Neuritis via Modulating Th1 Response.
Du T; Yang CL; Ge MR; Liu Y; Zhang P; Li H; Li XL; Li T; Liu YD; Dou YC; Yang B; Duan RS
Front Immunol; 2020; 11():1603. PubMed ID: 32793234
[TBL] [Abstract][Full Text] [Related]
9. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
10. Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
Ding Y; Han R; Jiang W; Xiao J; Liu H; Chen X; Li X; Hao J
J Immunol; 2016 Nov; 197(10):3831-3840. PubMed ID: 27798164
[TBL] [Abstract][Full Text] [Related]
11. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Prochazkova J; Pokorna K; Holan V
Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
[TBL] [Abstract][Full Text] [Related]
12. Can IFN-γ be a therapeutic target in Guillain-Barré syndrome?
Zhang HL; Wu L; Wu X; Zhu J
Expert Opin Ther Targets; 2014 Apr; 18(4):355-63. PubMed ID: 24479493
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells and NKR-P1(+) cells.
Xu H; Li XL; Yue LT; Li H; Zhang M; Wang S; Wang CC; Duan RS
J Neuroimmunol; 2014 Apr; 269(1-2):28-37. PubMed ID: 24565076
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
[TBL] [Abstract][Full Text] [Related]
15. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
Stürner KH; Verse N; Yousef S; Martin R; Sospedra M
Eur J Immunol; 2014 Apr; 44(4):1200-12. PubMed ID: 24469975
[TBL] [Abstract][Full Text] [Related]
16. IL-18 deficiency inhibits both Th1 and Th2 cytokine production but not the clinical symptoms in experimental autoimmune neuritis.
Duan RS; Zhang XM; Mix E; Quezada HC; Adem A; Zhu J
J Neuroimmunol; 2007 Feb; 183(1-2):162-7. PubMed ID: 17218016
[TBL] [Abstract][Full Text] [Related]
17. [Th17/Treg unbalance is involved in the pathogenesis of experimental autoimmune encephalomyelitis].
Lu P; Wang M; Zheng P; Hou J; Zhang Y; Deng Y; Cao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1013-7. PubMed ID: 25270199
[TBL] [Abstract][Full Text] [Related]
18. Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis.
Rani L; Minz RW; Sharma A; Anand S; Gupta D; Panda NK; Sakhuja VK
Cytokine; 2015 Feb; 71(2):261-7. PubMed ID: 25461407
[TBL] [Abstract][Full Text] [Related]
19. Th1/Th2/Th17/Treg expression in cultured PBMCs with antiphospholipid antibodies.
Xiao J; Zhu F; Liu X; Xiong J
Mol Med Rep; 2012 Nov; 6(5):1035-9. PubMed ID: 22941119
[TBL] [Abstract][Full Text] [Related]
20. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis.
Duan RS; Chen Z; Bao L; Quezada HC; Nennesmo I; Winblad B; Zhu J
Neurobiol Dis; 2004 Aug; 16(3):630-7. PubMed ID: 15262275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
